As of June 9, 2026, the Ebola outbreak in the Democratic Republic of Congo (DRC) and Uganda has been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO), with 363 confirmed cases and 63 deaths in DRC, and 16 cases and one death in Uganda. The Bundibugyo virus, which lacks a targeted vaccine, is spreading in a region already strained by conflict and weak health infrastructure, while the dismantling of the U.S. Agency for International Development (USAID) has exacerbated response challenges, according to a former USAID health official.
The Role of USAID Cuts in the Outbreak
The suspension of USAID’s operations, which began in 2025, has been cited as a critical factor in the delayed detection and containment of the Ebola outbreak. “There are things that normally we would have in place that are no longer there,” a former USAID health official based in Nairobi told Slate, referencing the erosion of surveillance systems, early warning mechanisms, and healthcare worker networks. This withdrawal, part of a broader U.S. policy shift toward reducing foreign aid, has left gaps in the region’s ability to track and respond to the virus. Meanwhile, Kenya’s recent protests over quarantine protocols for Ebola-exposed Americans highlight the political and public health tensions surrounding cross-border containment efforts.
Expert Insights on Ebola Transmission and Vaccines
Dr. Mohammad Shakeel Salat, an infectious disease specialist at Fortis Bengaluru, emphasized the virus’s high fatality rate but noted that it differs significantly from COVID-19. “Case fatality rates often approach 90 percent, but with the current outbreak, it is about 40%,” he said during an interview with Mashable India. He clarified that Ebola spreads through direct contact with bodily fluids, not respiratory routes, and that while two vaccines exist, they are not effective against the Bundibugyo strain. “Outbreaks are generally local, but an incubating person traveling abroad could spark distant cases,” he warned, urging vigilance without panic.
Comparing the Current Crisis to Past Outbreaks
This outbreak marks a stark contrast to the 2014 West Africa Ebola crisis, which saw a case fatality rate of around 40% but was contained through international coordination. The current situation, however, is compounded by the DRC’s ongoing conflicts in Ituri province, where mining towns serve as hotspots for transmission due to their transient populations and poor sanitation. Unlike the 2014 response, which involved a robust vaccine trial, the absence of a targeted vaccine for Bundibugyo has left health workers relying on experimental treatments and isolation protocols. “Feeding USAID into the wood chipper,” as one analyst put it, has left the region vulnerable to repeated outbreaks.
Global Implications and Next Steps
The WHO has called for increased funding and cross-border collaboration to prevent regional spread, but donor nations remain hesitant. Meanwhile, India’s health ministry has issued guidelines for monitoring travelers from affected areas, though no cases have been reported domestically. Dr. Shakeel stressed the importance of public education: “Rely on official updates, not social media rumors.” As the outbreak enters its third month, the international community faces a critical test in balancing humanitarian aid with geopolitical priorities. With the U.S. and other donors retreating, the responsibility for containing the crisis falls increasingly on local health systems already stretched thin.
“Surveillance systems, early warning systems, and just the number of healthcare workers” — these are the tools that have been eroded, leaving the DRC and Uganda to fight a battle they may not be equipped to win. The coming weeks will determine whether global leaders can reverse course or if this outbreak will become a defining failure of 21st-century public health governance.
